Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of KAL-002 for prevention of radiation enteritis
CTR20261815Phase 2Active
- Sponsor
- Anaerobio
- Start
- Jun 2026
- Modality
- Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of KAL_002 in radiation enteritis, sponsored by Anaerobio. Started Jun 2026; status: active.
02
Drugs
KAL_002
03
Conditions
radiation enteritis
Beyond the preview
Go deeper on CTR20261815.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20261815.